3B BLACKBIO DX
|
3B BLACKBIO DX Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 37.46 | 30.28 | 42.98 | 152.00 | 10.25 |
| CEPS(Rs) | 38.70 | 31.28 | 43.88 | 152.82 | 10.98 |
| DPS(Rs) | 3.00 | 2.50 | 10.50 | 1.00 | 0.70 |
| Book NAV/Share(Rs) | 260.32 | 225.60 | 204.26 | 176.27 | 42.87 |
| Tax Rate(%) | 27.59 | 26.54 | 25.50 | 25.10 | 23.52 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 44.49 | 47.08 | 46.00 | 66.15 | 32.27 |
| EBIT Margin(%) | 59.98 | 57.42 | 53.73 | 67.15 | 35.97 |
| Pre Tax Margin(%) | 59.81 | 57.10 | 53.60 | 67.05 | 34.81 |
| PAT Margin (%) | 43.31 | 41.94 | 39.93 | 50.22 | 26.62 |
| Cash Profit Margin (%) | 44.73 | 43.34 | 40.76 | 50.49 | 28.48 |
| Performance Ratios | |||||
| ROA(%) | 13.89 | 12.77 | 16.70 | 95.54 | 18.94 |
| ROE(%) | 15.42 | 14.98 | 22.59 | 138.73 | 28.15 |
| ROCE(%) | 21.21 | 20.24 | 29.92 | 179.46 | 32.29 |
| Asset Turnover(x) | 0.32 | 0.30 | 0.42 | 1.90 | 0.71 |
| Sales/Fixed Asset(x) | 5.26 | 4.74 | 7.17 | 23.54 | 3.38 |
| Working Capital/Sales(x) | 0.70 | 0.62 | 1.25 | 3.01 | 0.93 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.19 | 0.21 | 0.14 | 0.04 | 0.30 |
| Receivable days | 172.80 | 188.65 | 146.56 | 44.04 | 242.80 |
| Inventory Days | 40.55 | 45.68 | 27.85 | 7.20 | 57.29 |
| Payable days | 61.16 | 70.42 | 37.45 | 22.43 | 100.56 |
| Valuation Parameters | |||||
| PER(x) | 20.54 | 13.73 | 7.94 | 1.87 | 7.08 |
| PCE(x) | 19.89 | 13.29 | 7.78 | 1.86 | 6.61 |
| Price/Book(x) | 2.96 | 1.84 | 1.67 | 1.62 | 1.69 |
| Yield(%) | 0.39 | 0.60 | 3.08 | 0.35 | 0.96 |
| EV/Net Sales(x) | 8.07 | 4.83 | 2.84 | 0.79 | 1.68 |
| EV/Core EBITDA(x) | 13.14 | 8.22 | 5.21 | 1.18 | 4.44 |
| EV/EBIT(x) | 13.45 | 8.42 | 5.29 | 1.18 | 4.67 |
| EV/CE(x) | 2.67 | 1.53 | 1.47 | 1.34 | 1.36 |
| M Cap / Sales | 8.90 | 5.76 | 3.17 | 0.94 | 1.88 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 19.87 | -23.32 | -64.43 | 685.26 | 24.05 |
| Core EBITDA Growth(%) | 25.14 | -17.34 | -71.22 | 1,300.36 | 37.12 |
| EBIT Growth(%) | 25.20 | -18.05 | -71.54 | 1,366.08 | 40.08 |
| PAT Growth(%) | 23.77 | -19.45 | -71.72 | 1,381.27 | 46.66 |
| EPS Growth(%) | 23.74 | -29.55 | -71.72 | 1,383.24 | 24.95 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.01 | 0.02 | 0.02 | 0.11 |
| Current Ratio(x) | 7.04 | 8.05 | 4.82 | 2.76 | 4.82 |
| Quick Ratio(x) | 6.56 | 7.49 | 4.38 | 2.64 | 4.32 |
| Interest Cover(x) | 357.37 | 178.97 | 407.23 | 666.83 | 31.08 |
| Total Debt/Mcap(x) | - | 0.01 | 0.01 | 0.01 | 0.06 |
Compare Financial Ratios of peers of 3B BLACKBIO DX
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| 3B BLACKBIO DX | ₹1,664.4 Cr | -13.6% | -15.3% | 135.2% | Stock Analytics | |
| PI INDUSTRIES | ₹50,840.7 Cr | -4.1% | -10% | 6.9% | Stock Analytics | |
| UPL | ₹45,464.3 Cr | -0.4% | 7.9% | 7.4% | Stock Analytics | |
| SUMITOMO CHEMICAL INDIA | ₹24,790.1 Cr | 3% | -2.5% | 22.4% | Stock Analytics | |
| BAYER CROPSCIENCE | ₹21,572.4 Cr | -2.3% | -15.6% | -14.7% | Stock Analytics | |
| BASF INDIA | ₹19,566.4 Cr | -4.5% | -17% | 56.7% | Stock Analytics | |
3B BLACKBIO DX Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| 3B BLACKBIO DX | -13.6% |
-15.3% |
135.2% |
| SENSEX | 0.1% |
-3.6% |
7.9% |
You may also like the below Video Courses
